EGFR and non-small cell lung carcinoma: This genome-wide DNA methylation analysis identified two significant differentially methylated changes associated with NSCLC, six changes associated with EGFR mutation, and four changes associated with advanced stage in peripheral blood samples obtained from patients with NSCLC.